NIGMS Technology Development Programs (R21 and R01)

NIGMS Technology Development Programs (R21 and R01): The technology development R21 and R01 funding opportunity announcements (FOAs) support technological innovations to advance biomedical research. Example technologies, which might originate from biomedical, engineering or physical sciences disciplines, include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. The FOAs support the earliest stages of technology development, establishing feasibility/proof of concept and prototype validation, and do not support applications that address new biological questions.

Technology Stage

Funding Opportunity

Proof of Concept and Value
Exploratory Research / Technology Feasibility

Right arrow graphic.

 
 

Down arrow graphic.

 
 
 
 

Prototype Validation
Iterative Technology R&D / Validation Studies

Right arrow graphic.

 
 

Down arrow graphic.

 
 
 
 

Addressing Biological Question
Applied technology R&D and Dissemination

Right arrow graphic.

 
 

Send your questions about the programs to the NIGMS tech dev contact mailbox.

​​​